World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 9 January 2017
Main ID:  NCT03009552
Date of registration: 28/12/2016
Prospective Registration: No
Primary sponsor: Marco Stephan Lofrano Alves
Public title: Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure STRAIN-DHF
Scientific title: Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure
Date of first enrolment: June 2016
Target sample size: 176
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03009552
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Brazil
Contacts
Name:     Marco Stephan L Alves, MD
Address: 
Telephone: +55 11 26615646
Email: mslalves@hotmail.com
Affiliation: 
Name:     Marco Stephan L Alves, MD
Address: 
Telephone: +55 11 981431512
Email: mslalves@hotmail.com
Affiliation: 
Name:     Marco Stephan L Alves, MD
Address: 
Telephone:
Email:
Affiliation:  University of Sao Paulo
Key inclusion & exclusion criteria

Inclusion Criteria:

- Admission in the emergency for decompensated heart failure.

Exclusion Criteria:

- Systolic blood pressure < 85, need surgical treatment, high ventricular frequency
atrial fibrillation or flutter, severe pulmonary disease, pulmonary embolism, septic
shock, advanced malignant neoplasia, pregnancy, heart transplant.



Age minimum: 18 Years
Age maximum: 75 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Decompensated Heart Failure
Intervention(s)
Procedure: speckle tracking echocardiography
Primary Outcome(s)
Composite endpoint of mortality, heart transplant, left ventricular assist device and readmission for decompensated heart failure. [Time Frame: Six months after admission]
Secondary Outcome(s)
Development of cardio-renal syndrome (loss of more than 30% of calculated creatinine clearance or need for dialysis) [Time Frame: 1 month after admission]
Cardiac mortality [Time Frame: 6 months]
Secondary ID(s)
2015/10005-5
CAAE:59669416.0.0000.0068
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history